6-Alkoxymethyl-3-hydroxy-4H-pyranones: Potential ligands for cell-labelling with indium

European Journal of Nuclear Medicine

Volumn 26, Issue 11, 1999, Pages 1400-1406

  Ellis, Beverley L ^a   Sampson, Charles B ^b   Abeysinghe, Rajeewa D ^c   Porter, John B ^c   Hider, Robert C ^d  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c The Medical School   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Hydroxypyranones; Indium; Leucocytes; Platelets; Radiolabelling

Indexed keywords

3 HYDROXY 6 PROPOXYMETHYL 4H PYRAN 4 ONE; 6 BUTOXYMETHYL 3 HYDROXY 4H PYRAN 4 ONE; INDIUM 111; LIGAND; PYRAN DERIVATIVE; PYRANONE; RADIOISOTOPE; TROPOLONE IN 111; UNCLASSIFIED DRUG;

ARTICLE; CELL LABELING; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; ISOTOPE LABELING; LEUKOCYTE; THROMBOCYTE; THROMBOCYTE FUNCTION;

ALKANES; ERYTHROCYTES; HUMANS; INDIUM RADIOISOTOPES; ISOTOPE LABELING; LIGANDS; LYMPHOCYTES; NEUTROPHILS; PYRANS; TROPOLONE;

EID: 0032747323     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050471     Document Type: Article

References (36)

1. Danpure HJ. Cell-labelling with rain complexes. In: Theobald AE, ed. Radiopharmacy and radiopharmaceuticals. London: Taylor and Francis; 1985:51-185.
2. McAfee JG, Subramanian G, Gagne G. Technique of leukocyte harvesting and labeling: problems and perspectives. Semin Nucl Med 1984; 14:83-107.
3. Peters AM, Saverymuttu SH. The value of indium-labelled leukocytes in clinical practice. Blood Rev 1987; 1:65-76.
4. Sampson CB. Labelled cells for imaging infection. In: Cox PH, Buscombe J, eds. The imaging of infection and inflammation. Dordrecht: Kluwer Academic; 1998:31-57.
5. Thakur ML, Seifert CL, Madsen MT, McKenny SM, Desai AG, Park CH. Neutrophil labeling. Problems and pitfalls. Semin Nucl Med 1984; 14:107-117.
6. Weiblen BJ, Forstrom L, McCullough J. Studies of the kinetics of indium-111-labeled granulocytes. J Lab Clin Med 1979; 94:246-255.
7. Lavender JP, Goldman JM, Arnot RN, Thakur ML. Kinetics of indium-111 labelled lymphocytes in normal subjects and patients with Hodgkin's disease. Br Med J 1977:797-799.
8. Wagstaff J, Gibson C, Thatcher N, Ford NL, Sharma H, Benson W, Crowther D. A method for following human lymphocyte traffic using indium-111 oxine labelling. Clin Exp Immunol 1981; 43:435-442.
9. 111In)-labelled human platelets: optimal method. Clin Sci 1980; 58:243-248.
10. International Committee for Standardization in Haematology (ICSH). Recommended method for indium-111 platelet survival studies. J Nucl Med 1988; 29:564-566.
11. Mathias CJ, Welch MJ. Radiolabeling of platelets. Semin Nucl Med 1984; 14:118-127.
12. Thakur ML, Walsh L, Malech HL, Gottsehalk A. Indium-111-labeled human platelets: improved method, efficacy, and evaluation. J Nucl Med 1981; 22:381-385.
13. 111In-tropolonate. Eur J Nucl Med 1988; 13:537-542.
14. Thakur ML. Editorial. Cell labeling: achievements, challenges, and prospects. J Nucl Med 1981; 22:1011-1014.
15. Dewanjee MK, Rao SA, Didsheim P. Indium-111 tropolone, a new high-affinity platelet label: preparation and evaluation of labeling parameters. J Nucl Med 1981; 22:981-987.
16. Peters AM, Saverymuttu SH, Reavy HJ, Danpure HJ, Osman S, Lavender JP. Imaging of inflammation with indium-111 tropolonate labeled leukocytes. J Nucl Med 1983; 24:39-44.
17. Thakur ML, McKenny S. Techniques of cell labeling: An overview. In: Ezikowitz MD, Hardeman MR, eds. Radiolabeled cellular blood elements, pathology, techniques and scintigraphic applications. New York: Plenum; 1985:67-87.
18. Thakur ML, Lavender JP, Arnot RN, Silvester DJ, Segal AW. Indium-111-labeled autologous leukocytes in man. J Nucl Med 1977; 18:1012-1019.
19. Thakur ML, Segal AW, Louis L, Welch MJ, Hopkins J, Peters TJ. Indium-111-labeled cellular blood components: mechanism of labeling and intracellular location in human neutrophils. J Nucl Med 1977; 18:1020-1024
20. Balaban EP, Simon TR, Sheehan RG, Frenkel EP. Effect of the radiolabel mediator tropolone on lymphocyte structure and function. J Lab Clin Med 1986; 107:306-314.
21. Chisholm PM, Danpure HJ, Healey G, Osman S. Cell damage resulting from the labeling of rat lymphocytes and HeLa S3 cells with In-111 oxine. J Nucl Med 1979; 20:1308-1311.
22. Kassis AI, Adelstein SJ. Chemotoxicity of indium-111 oxine in mammalian cells. J Nucl Med 1985; 26:187-190.
23. Segal AW, Deteix P, Garcia R, Tooth P, Zanneli GD, Allison AC. Indium-111 labeling of leukocytes: a detrimental effect on neutrophil and lymphocyte function and an improved method of cell labelling. J Nucl Med 1978; 19:1238-1244.
24. ten Berge RJM, Natarajan AT, Hardeman MR, van Royen EA, Schellekens PT. Labeling with indium-111 has detrimental effects on human lymphocytes: concise communication. J Nucl Med 1983; 24:615-620.
25. Hider RC, Hall AD. Clinically useful chelators of tripositive elements. In: Ellis GP, West GB, eds. Progress in medicinal chemistry. New York: Elsevier Science; 1991:41-173.
26. Gralla EJ, Stebbins RB, Coleman GL, Delahunt CS. Toxicity studies with ethyl maltol. Toxicol Appl Pharmacol 1969; 15:604-613.
27. Rennhard HH. The metabolism of ethyl maltol in the dog. J Agric Food Chem 1971; 19:152-154.
28. Ellis BL, Duhme AK, Hider RC, Hossain MB, Rizvi S, van der Helm D. Synthesis, physicochemical properties and biological evaluation of hydroxypyranones and hydroxypyridinones: novel bidentate ligands for cell labeling. J Med Chem 1996; 39:3659-3670.
29. Sampson CB, Solanki C. Separation and technetium labelling of pure neutrophils: development of a simple and rapid clinical protocol. Nucl Med Commun 1992; 13:210.
30. Sampson CB. Separation and radiolabeling of lymphocytes: a plain man's guide. Nucl Med Commun 1992; 13:400.
31. Valeri CR, Valeri DA, Gray A, Melaragno A, Dennis RC, Emerson CP. Viability and function of red blood cell concentrates stored at 4°C for 35 days in CPDA-1, CPDA-2 or CPDA-3. Transfusion 1982; 22:210-216.
32. Abeysinghe RD, Ellis BL, Hider RC, Porter JB. Platelet labelling with indium-hydroxypyridinone and indium-hydroxypyranone complexes. Eur J Nucl Med 1994; 21:1141-1147.
33. Abeysinghe RD, Roberts PJ, Cooper CE, MacLean KH, Hider RC, Porter JB. The environment of the lipoxygenase iron binding site explored with novel hydroxypyridinone iron chelators. J Biol Chem 1996; 271:7965-7972.
34. Hoyes KP, Hider RC, Porter JB. Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell lines. Cancer Res 1992; 52:4591-4599.
35. Cooper CE, Lynagh GR, Hoyes KP, Hider RC, Cammack R, Porter JB. The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase. J Biol Chem 1996; 271:20291-20299.
36. Roddie ME, Peters AM, Danpure HJ, Osman S, Henderson BL, Lavender JP, Carroll MJ, Kelly JD, Neirinckx RD. Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes. Radiology 1988; 166:767-772.